000 | 01036 a2200277 4500 | ||
---|---|---|---|
005 | 20250517143242.0 | ||
264 | 0 | _c20170515 | |
008 | 201705s 0 0 eng d | ||
022 | _a1177-8881 | ||
024 | 7 |
_a10.2147/DDDT.S103468 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCoppola, Giangennaro | |
245 | 0 | 0 |
_aNew developments in the management of partial-onset epilepsy: role of brivaracetam. _h[electronic resource] |
260 |
_bDrug design, development and therapy _c2017 |
||
300 |
_a643-657 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
650 | 0 | 4 |
_aEpilepsies, Partial _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPyrrolidinones _xadministration & dosage |
700 | 1 | _aIapadre, Giulia | |
700 | 1 | _aOperto, Francesca Felicia | |
700 | 1 | _aVerrotti, Alberto | |
773 | 0 |
_tDrug design, development and therapy _gvol. 11 _gp. 643-657 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S103468 _zAvailable from publisher's website |
999 |
_c26968018 _d26968018 |